Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products

Published January 2016 | 33 Exhibits | Forecasts Through 2020

Subscribe Now

Request Info

Order individually or subscribe and get a complete intel platform.

Buy This Report

Subscribe To All Reports

Overview

About the global market:
The global market for specialty surgical wound care products-which includes sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.2 billion in 2014. The main factor influencing growth in the market is surgical volumes; rising numbers of surgeries in major global markets will generate greater revenues through 2020, when total sales are projected to reach $4.4 billion. Sales of absorbable hemostats and adhesion prevention products are expected to increase at the swiftest rates, followed by surgical glues and sealants.

Factors driving growth through 2020 include the following:
1. Rising surgical volumes due to greater access to healthcare in the U.S. and emerging markets. Favorable demographics in mature markets such as Japan and Western Europe should generate mild increases in annual caseloads;
2. Growing utilization in emerging markets and important surgical applications, such as cardiothoracic surgery and neurosurgery; and
3. New product introductions which will help to sustain pricing levels.

Factors limiting growth through 2020 include the following:
1. Cost-containment efforts in key regional markets, such as Europe, which should lead to price erosion;
2. Important shifts in surgical technique, such as the rising use of laparoscopy in gastrointestinal surgery; and
3. The relative maturity of important segments, such as surgical glues for open surgical repairs of the aorta, carotid, and femoral arteries.

Leading suppliers to the global market include Ethicon (Johnson & Johnson); Baxter International; Genzyme (Sanofi-Aventis); Takeda Pharmaceuticals International; King Pharmaceuticals (Pfizer); The Medicines Company; Integra LifeSciences; and CryoLife. Other suppliers included CSL Behring; Davol, Neomend, and Medafor (C.R. Bard); HemCon Medical Technologies; Hyperbranch Medical Technology; MAST Biosurgery; Orthovita (Stryker); Tenaxis Medical; ThermoGenesis; Tissuemed; and Vivostat A/S.

Companies Covered

Baxter International
CryoLife
CSL Behring
Davol
Ethicon (Johnson & Johnson)
Genzyme (Sanofi-Aventis)
HemCon Medical Technologies
Hyperbranch Medical Technology
Integra LifeSciences
King Pharmaceuticals (Pfizer)
MAST Biosurgery
Medafor (C.R. Bard)
Neomend
Orthovita (Stryker)
Takeda Pharmaceuticals International
Tenaxis Medical
ThermoGenesis
Tissuemed
Vivostat A/S
Zymogenetics (Bristol-Myers Squibb)

Market Model 1-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products
by Product Type
Market Model 1-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products
by Region
Market Model 1-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products
by Product Type
Market Model 1-4: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention
Products by Product Type
Market Model 1-5: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention
Products by Product Type
Market Model 1-6: Global Supplier Shares in 2013 and 2014
Market Model 2-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention 
Products by Product Type
Market Model 2-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention 
Products by Region
Market Model 2-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention 
Products by Product Type
Market Model 2-4: Targeted Surgical Caseloads in the U.S. from 2013-2020
Market Model 2-5: The U.S. Market Forecast for External and Internal Tissue Sealants from 2013-2020
Market Model 2-6: The U.S. Market Forecast for Surgical Glues from 2013-2020
Market Model 2-7: The U.S. Market Forecast for Surgical Glues, Approved & Off-Label Uses, from 2013-2020
Market Model 2-8: The U.S. Market Forecast for Absorbable Hemostats from 2013-2020
Market Model 2-9: The U.S. Market Forecast for Adhesion Prevention Products from 2013-2020
Market Model 2-10: U.S. Supplier Shares in 2013 and 2014
Market Model 2-11: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
Market Model 2-12: Targeted Surgical Caseloads in Europe from 2013-2020
Market Model 2-13: The European Market Forecast for Surgical Sealants from 2013-2020
Market Model 2-14: The European Market Forecast for External and Internal Tissue Sealants from 2013-2020
Market Model 2-15: The European Market Forecast for Surgical Glues from 2013-2020
Market Model 2-16: The European Market Forecast for Surgical Glues from 2013-2020: Open Repairs of the Large Vessels & Other Indications
Market Model 2-17: The European Market Forecast for Absorbable Hemostats from 2013-2020
Market Model 2-18: The European Market Forecast for Adhesion Prevention Products from 2013-2020
Market Model 2-19: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
Market Model 2-20: Targeted Surgical Caseloads in AP & ROW Countries from 2013-2020
Market Model 2-21: The AP & ROW Market Forecast for Surgical Sealants from 2013-2020
Market Model 2-22: The AP & ROW Market Forecast for External and Internal Tissue Sealants from 2013-2020
Market Model 2-23: The AP & ROW Market Forecast for Surgical Glues from 2013-2020
Market Model 2-24: The AP & ROW Market Forecast for Surgical Glues from 2013-2020: Open Repairs of the Large Vessels & Other Indications
Market Model 2-25: The AP & ROW Market Forecast for Absorbable Hemostats from 2013-2020
Market Model 2-26: The AP & ROW Market Forecast for Adhesion Prevention Products from 2013-2020
Market Model 2-27: OUS Supplier Shares in 2013 and 2014

Ready to get started?

We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.